Refine Search
...warning: "By 2030, more than half of Americans could be obese, resulting in millions of new cases of diabetes, coronary heart disease, and stroke - a constellation of illness that could cost the United States up to $66 billion in treatment and...
SCOTTSDALE, Ariz. - Paul Gordon Fink, 60, formerly of Aitkin, died unexpectedly of coronary heart disease the evening of July 9, 2011, in Scottsdale, Ariz. Funeral services are pending at Sorensen-Root-Thompson Funeral Home in Aitkin.
AITKIN - Paul Gordon Fink, 60, formerly of Aitkin, died unexpectedly of coronary heart disease the evening of July 9, 2011, in Scottsdale, Ariz. He was born April 9, 1951, in Jackson. He lived a remarkable and adventurous...
SCOTTSDALE, Ariz. - Paul Gordon Fink, 60, formerly of Aitkin, died unexpectedly of coronary heart disease the evening of July 9, 2011, in Scottsdale, Ariz. He was born April 9, 1951, in Jackson. He lived a remarkable and adventurous...
...strong predictor for adult obesity and other chronic ailments such as hypertension, high blood cholesterol, coronary heart disease, stroke and cancer. The chances of an overweight adolescent reaching a normal adult weight is less than 50 percent...
...blood cholesterol level, specifically high LDL or bad cholesterol, dramatically reduces a person's risk for coronary heart disease," said Dr. Claude Lenfant, director of the National Heat, Lung and Blood Institute. If the guidelines are...
...uninsured and underinsured women. The cardiac panel test will analyze lipid levels and help determine the risk of coronary heart disease. Lipid levels can indicate the likelihood of a heart attack or stroke caused by blockage of blood vessels or...
...and $100 billion a year, according to P.E.4Life. And an inactive lifestyle can almost double the risk of coronary heart disease. The percentage of overweight young people has more than doubled in the past three decades, according to the...
...chairman of an ongoing trial that will compare mortality and heart attack rates of more than 3,000 patients with coronary heart disease. The $35-million trial is being conducted at 43 sites in the United States and Canada and is known by the...